Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown. We previously determined, first, that metabolic endotoxemia controls the inflammatory tone, body weight gain, and diabetes, and second, that high-fat feeding modulates gut microbiota and the plasma concentration of lipopolysaccharide (LPS), i.e., metabolic endotoxemia. Therefore, it remained to demonstrate whether changes in gut microbiota control the occurrence of metabolic diseases. RESEARCH DESIGN AND METHODS—We changed gut microbiota by means of antibiotic treatment to demonstrate, first, that changes in gut microbiota could be responsible for the control of metabolic endotoxemia, the low-grade inflammation, obesity, and type 2 diabetes and, second, to provide some mechanisms responsible for such effect. RESULTS—We found that changes of gut microbiota induced by an antibiotic treatment reduced metabolic endotoxemia and the cecal content of LPS in both high-fat–fed and ob/ob mice. This effect was correlated with reduced glucose intolerance, body weight gain, fat mass development, lower inflammation, oxidative stress, and macrophage infiltration marker mRNA expression in visceral adipose tissue. Importantly, high-fat feeding strongly increased intestinal permeability and reduced the expression of genes coding for proteins of the tight junctions. Furthermore, the absence of CD14 in ob/ob CD14−/− mutant mice mimicked the metabolic and inflammatory effects of antibiotics. CONCLUSIONS—This new finding demonstrates that changes in gut microbiota controls metabolic endotoxemia, inflammation, and associated disorders by a mechanism that could increase intestinal permeability. It would thus be useful to develop strategies for changing gut microbiota to control, intestinal permeability, metabolic endotoxemia, and associated disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bacterial translocation can be defined as the passage of bacteria, or bacterial products such as LPS, into the portal circulation and happens when the complex regulation of the mechanisms of the gut barrier is lost [276], which has been linked with the occurrence of NAFLD, NASH, hepatic fibrosis, and HCC in several rodent models [227,228,277].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [276]
In the citing paper
“Penetration of lipopolysaccharide into the bloodstream is controlled by the integrity of the gut barrier.”
From Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe −/− Mice (2016) · cites this paper as [48]
In the citing paper
“In obese rodents, antibiotics and prebiotics were able to restore gut barrier integrity and metabolic functions, providing evidence for the gut barrier as a mediator of microbiota-induced systemic inflammation [98,99].”
Citations
Cites
1 retracted
Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A., et al. (2007) · Diabetes · doi:10.2337/db06-1595 · Cited by 826 · cited 3×
“We and others have recently demonstrated that the mechanisms of highfat diet-induced inflammation and metabolic disorders were clearly linked to LPS (4;24-28).”
BackgroundResultRetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 7×
“Inflammation: PAI-1, IL-1, and TNF- mRNA concentrations (A, D and G); oxidative stress: STAMP-2 and NADPHox mRNA concentrations (B and E); macrophage infiltration markers: MCP-1 and F4/80 mRNA concentrations (C and F) in mice fed normal diet (CT), normal diet and antibiotics (CT-Ab), high-fat diet (HF), or high-fat di…”
ResultInfluentialInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Diabetes and obesity are characterized by a low-grade inflammation whose molecular origin is unknown (2,3).”
BackgroundHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 2×
“Gut microbiota has recently been proposed as an environmental factor involved in the control of body weight and energy homeostasis (7-12).”
BackgroundResultMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 16×
“Although the reasons for its increase in plasma during high-fat feeding were undetermined, its levels were closely correlated but not causatively demonstrated, with changes in intestinal microbiota where the Gram negative–to–Gram positive ratio increased during high-fat feeding (4).”
BackgroundMethodResultSelf-citationThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Germ-free mice of the same age and genetic background as conventional mice fed with a normal chow diet had a 40% lower weight (11), whereas germ-free mice colonized with the gut microbiota derived from the conventional mice increased their fat mass and developed insulin resistance within 2 weeks.”
BackgroundObesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176 · cited 1×
“These animals are characterized by different gut microbiota (8,12), higher inflammatory tone, and endotoxemia when compared with wild-type mice (23).”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“Oxidative stress is frequently associated with inflammation and metabolic dysfunction in adipose depots (20-22).”
BackgroundMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Diabetes 57:1470–1481, 2008 Environmental factors, such as a fat-enriched diet and a sedentary lifestyle, are the causes of the great prevalence of obesity and type 2 diabetes in the population (1).”
Background
Cited by
Items 401–500 of 1,065
Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity
Sen, T., Cawthon, C. R., Ihde, B. T., Hajnal, A., DiLorenzo, P. M., de La Serre, C. B., & Czaja, K. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.02.027 · Cited by 239
“A leaky gut allows for LPS translocation to the general circulation and promotes systemic inflammation [7].”
InfluentialObesity-associated NLRC4 inflammasome activation drives breast cancer progression
Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13007 · Cited by 239
Cândido, F. G., Valente, F. X., Grześkowiak, Ł. M., Moreira, A. P. B., Rocha, D. M. U. P., & Alfenas, R. D. C. G. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1343286 · Cited by 239
“Reduction in the expression of tight junction proteins was observed in intestinal mucosa of animals receiving high-fat diets (Cani et al. 2008; de La Serre et al. 2010; Suzuki and Hara 2010).”
BackgroundHost- and Microbiota-Derived Extracellular Vesicles, Immune Function, and Disease Development
Macia, L., Nanan, R., Hosseini-Beheshti, E., & Grau, G. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010107 · Cited by 237
Practical considerations for large-scale gut microbiome studies
Vandeputte, D., Tito, R. Y., Vanleeuwen, R., Falony, G., & Raes, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux027 · Cited by 238
“2011), inflammation (Cani et al. 2008) and antibiotic usage (Lozupone et al.”
BackgroundEverard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R. G. P., Cochez, P., Pierard, F., Castel, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6648 · Cited by 237
“…intestinal epithelial MyD88-deleted mice (IEC MyD88-KO) were generated by crossing mice bearing a tamoxifen-dependent Cre recombinase expressed under the control of the villin promoter ( Villin Cre-ERT2 ) with mice harbouring a loxP -flanked Myd88 allele (C57BL/6 background, Jackson-Laboratory).”
Self-citationTherapeutic Modulation of Microbiota-Host Metabolic Interactions
Holmes, E., Kinross, J., Gibson, G. R., Burcelin, R., Jia, W., Pettersson, S., & Nicholson, J. K. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004244 · Cited by 236
“The recent discovery that the phylotypic ecology of the intestinal microbiota is markedly altered in response to a fat-enriched diet in rodents (57) and in obese individuals (58) or in patients with type 2 diabetes (59) may help to answer this question.”
BackgroundSelf-citationDavey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236
Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases
Taleb, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02113 · Cited by 236
Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
De Angelis, M., Montemurno, E., Piccolo, M., Vannini, L., Lauriero, G., Maranzano, V., Gozzi, G., Serrazanetti, D., Dalfino, G., Gobbetti, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099006 · Cited by 239
Overweight and diabetes prevention: Is a low-carbohydrate-high-fat diet recommendable?
Brouns, F. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1636-y · Cited by 235
Low-Grade Inflammation, Obesity, and Diabetes
Pereira, S. S., & Alvarez-Leite, J. I. (2014) · Current Obesity Reports · doi:10.1007/s13679-014-0124-9 · Cited by 233
Pan, F., Zhang, L., Li, M., Hu, Y., Zeng, B., Yuan, H., Zhao, L., & Zhang, C. (2018) · Microbiome · doi:10.1186/s40168-018-0440-5 · Cited by 232
Zinkernagel, M. S., Zysset-Burri, D. C., Keller, I., Berger, L. E., Leichtle, A. B., Largiadèr, C. R., Fiedler, G. M., & Wolf, S. (2017) · Scientific Reports · doi:10.1038/srep40826 · Cited by 229
The critical role of gut microbiota in obesity
Cheng, Z., Zhang, L., Yang, L., & Chu, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1025706 · Cited by 233
“At the phylum level, the Firmicutes abundance in T2DM was markedly decreased while the Bacteroidetes abundance was markedly increased compared to the controls (33), which was completely contrary to the corresponding results in obesity.”
BackgroundInfluentialLeaky gut and diabetes mellitus: what is the link?: Leaky gut in diabetes
de Kort, S., Keszthelyi, D., & Masclee, A. A. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00845.x · Cited by 233
Gil-Cardoso, K., Ginés, I., Pinent, M., Ardévol, A., Blay, M., & Terra, X. (2016) · Nutrition Research Reviews · doi:10.1017/s0954422416000159 · Cited by 231
“The causative link between changes in intestinal bacteria populations, endotoxaemia and metabolic disease needs further assessment((56)), but the mechanisms probably include altered epithelial permeability, translocation of bacterial products and up-regulation of pro-inflammatory cytokines and hormones produced by gut…”
BackgroundCao, H., Xu, M., Dong, W., Deng, B., Wang, S., Zhang, Y., Wang, S., Luo, S., Wang, W., Qi, Y., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30643 · Cited by 231
Wang, P., Gao, J., Ke, W., Wang, J., Li, D., Liu, R., Jia, Y., Wang, X., Chen, X., Chen, F., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.04.013 · Cited by 231
Delzenne, N. M., Neyrinck, A. M., & Cani, P. D. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-s1-s10 · Cited by 233
Self-citationBrown, K., Uwiera, R. R. E., Kalmokoff, M. L., Brooks, S. P. J., & Inglis, G. D. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.08.006 · Cited by 231
Yoo, S., Kim, Y., Park, D., Jung, U., Jeon, S., Ahn, Y., Huh, C., McGregor, R., & Choi, M. S. (2013) · Obesity · doi:10.1002/oby.20428 · Cited by 230
“Experimental manipulation of the gut microbiota affects the activation of the innate immune system (7,39).”
BackgroundNutrition Facts in Multiple Sclerosis
Riccio, P., & Rossano, R. (2015) · ASN Neuro · doi:10.1177/1759091414568185 · Cited by 230
Spiljar, M., Merkler, D., & Trajkovski, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01353 · Cited by 219
“Gut permeability is increased with HFD, in obesity and in diabetes (96).”
BackgroundThe role of the gut microbiota in dietary interventions for depression and anxiety
Bear, T. L. K., Dalziel, J. E., Coad, J., Roy, N. C., Butts, C. A., & Gopal, P. K. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa016 · Cited by 229
“These physiological effects of the HFD were able to be reduced with antibiotic treatment (221).”
BackgroundAxling, U., Olsson, C., Xu, J., Fernandez, C., Larsson, S., Ström, K., Ahrné, S., Holm, C., Molin, G., & Berger, K. (2012) · Nutrition & Metabolism · doi:10.1186/1743-7075-9-105 · Cited by 227
“Manipulation of the microbiota in mice using prebiotics [7] or antibiotics [8,9] has been shown to have beneficial effects on adiposity, glucose tolerance and inflammation.”
Hasain, Z., Mokhtar, N. M., Kamaruddin, N. A., Mohamed Ismail, N. A., Razalli, N. H., Gnanou, J. V., & Raja Ali, R. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00188 · Cited by 225
“Diet-induced obese and diabetic mice models were found to have altered normal gut microbiota composition, which impaired their gut epithelial barrier integrity through downregulation of tight junction protein expression, such as ZO-1 and occludin (Cani et al., 2008; Bagarolli et al., 2017).”
BackgroundImpact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia
Jia, X., Xu, W., Zhang, L., Li, X., Wang, R., & Wu, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.634780 · Cited by 226
Tulstrup, M. V.-L., Christensen, E. G., Carvalho, V., Linninge, C., Ahrné, S., Højberg, O., Licht, T. R., & Bahl, M. I. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144854 · Cited by 227
KONDO, S., XIAO, J.-Z., SATOH, T., ODAMAKI, T., TAKAHASHI, S., SUGAHARA, H., YAESHIMA, T., IWATSUKI, K., KAMEI, A., & ABE, K. (2010) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.100267 · Cited by 226
Fouhy, F., Ross, R. P., Fitzgerald, G. F., Stanton, C., & Cotter, P. D. (2012) · Gut Microbes · doi:10.4161/gmic.20169 · Cited by 225
“Among the most popular of those employed initially were temperature gradient gel electrophoresis (TGGE) and denaturing gradient gel electrophoresis (DGGE).(21) These systems work by the separation of amplicons [often of the 16S ribosomal RNA gene (rRNA)] based on their GC content, to reveal distinctive patterns.”
BackgroundMethodGPR43 Potentiates β-Cell Function in Obesity
McNelis, J. C., Lee, Y. S., Mayoral, R., van der Kant, R., Johnson, A. M. F., Wollam, J., & Olefsky, J. M. (2015) · Diabetes · doi:10.2337/db14-1938 · Cited by 224
Clostridium ramosum Promotes High-Fat Diet-Induced Obesity in Gnotobiotic Mouse Models
Woting, A., Pfeiffer, N., Loh, G., Klaus, S., & Blaut, M. (2014) · mBio · doi:10.1128/mbio.01530-14 · Cited by 225
Wang, J., Ghosh, S. S., & Ghosh, S. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00235.2016 · Cited by 214
“We and others have reported an increase in circulating LPS levels in response to WD feeding due to an increase in intestinal permeability (8, 12).”
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M., & Koga, Y. (2017) · Scientific Reports · doi:10.1038/srep43522 · Cited by 225
Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13010144 · Cited by 223
“proteins, allowing the translocation of lipopolysaccharide into the circulation [29,30].”
BackgroundInnate Immune Programing by Endotoxin and Its Pathological Consequences
Morris, M. C., Gilliam, E. A., & Li, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00680 · Cited by 224
Tilg, H., Moschen, A. R., & Kaser, A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.030 · Cited by 224
The Role of Gut Microbiota in Atherosclerosis and Hypertension
Ma, J., & Li, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01082 · Cited by 224
“…disease (CVD; Wang et al., 2011; Emoto et al., 2017), obesity (Ley et al., 2006; Henao-Mejia et al., 2012), type 2 diabetes mellitus (T2DM; Cani et al., 2008; Khan et al., 2014; Pedersen et al., 2016), nonalcoholic fatty liver disease (NAFLD; Mouzaki et al., 2013; Zhu et al., 2013), and…”
BackgroundMoreno-Navarrete, J. M., Ortega, F., Serino, M., Luche, E., Waget, A., Pardo, G., Salvador, J., Ricart, W., Frühbeck, G., Burcelin, R., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.256 · Cited by 223
Self-citationLam, Y. Y., Ha, C. W. Y., Hoffmann, J. M. A., Oscarsson, J., Dinudom, A., Mather, T. J., Cook, D. I., Hunt, N. H., Caterson, I. D., Holmes, A. J., et al. (2015) · Obesity · doi:10.1002/oby.21122 · Cited by 223
“Consistent with and extending previous results (3,4), HFD-sat was broadly deleterious.”
BackgroundResultInfluentialToral, M., Robles-Vera, I., de la Visitación, N., Romero, M., Yang, T., Sánchez, M., Gómez-Guzmán, M., Jiménez, R., Raizada, M. K., & Duarte, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00231 · Cited by 223
“In addition, an increase in intestinal permeability has been proposed as a crucial mechanism for the development of endotoxemia (Cani et al., 2008).”
BackgroundStenman, L. K., Holma, R., Eggert, A., & Korpela, R. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00267.2012 · Cited by 222
“Leptin-deficient obese mice have been reported to develop a leaky gut (3), whereas other authors have reported barrier dysfunction in diet-induced obese mice (4, 7).”
Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice
Mutlu, E. A., Engen, P. A., Soberanes, S., Urich, D., Forsyth, C. B., Nigdelioglu, R., Chiarella, S. E., Radigan, K. A., Gonzalez, A., Jakate, S., et al. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-19 · Cited by 220
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Sircana, A., Framarin, L., Leone, N., Berrutti, M., Castellino, F., Parente, R., De Michieli, F., Paschetta, E., & Musso, G. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1057-6 · Cited by 223
Kim, M., Hwang, S., Park, E., & Bae, J. (2013) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12079 · Cited by 220
“Endotoxininduced systemic inflammation, caused by lipopolysaccharides produced by the altered gut microbiota passing through the impaired intestinal barrier (Cani et al., 2008), is directly associated with a Western-style diet (Pendyala et al., 2012).”
BackgroundJiang, T., Gao, X., Wu, C., Tian, F., Lei, Q., Bi, J., Xie, B., Wang, H., Chen, S., & Wang, X. (2016) · Nutrients · doi:10.3390/nu8030126 · Cited by 220
“Recognition of LPS by Toll-like receptor 4 (TLR4) of host cells triggers downstream inflammatory events [23,24] that contributes to the development of obesity and metabolic disorders such as insulin resistance [10,25].”
BackgroundDistinctly altered gut microbiota in the progression of liver disease
Xie, G., Wang, X., Liu, P., Wei, R., Chen, W., Rajani, C., Hernandez, B. Y., Alegado, R., Dong, B., Li, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8466 · Cited by 219
“It has been shown that such changes in the gut microbiota may increase intestinal permeability and circulating gut-originated antigens, primarily LPS [31-34].”
BackgroundChoi, Y., Kwon, Y., Kim, D.-K., Jeon, J., Jang, S. C., Wang, T., Ban, M., Kim, M.-H., Jeon, S. G., Kim, M.-S., et al. (2015) · Scientific Reports · doi:10.1038/srep15878 · Cited by 218
Masumoto, S., Terao, A., Yamamoto, Y., Mukai, T., Miura, T., & Shoji, T. (2016) · Scientific Reports · doi:10.1038/srep31208 · Cited by 218
“In addition, there is growing evidence indicating that endotoxic lipopolysaccharide (LPS), derived from gram-negative bacteria, and chronic low-grade inflammation are associated with obesity and insulin resistance 19 .”
Gonzalez-Quintela, A., Alonso, M., Campos, J., Vizcaino, L., Loidi, L., & Gude, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054600 · Cited by 217
“Furthermore, lowering the LPS concentrations with antibiotics [44,45] could improve metabolic outcomes.”
BackgroundPlasma Lipopolysaccharide Is Closely Associated With Glycemic Control and Abdominal Obesity
Trøseid, M., Nestvold, T. K., Rudi, K., Thoresen, H., Nielsen, E. W., & Lappegård, K. T. (2013) · Diabetes Care · doi:10.2337/dc13-0451 · Cited by 217
“This metabolic endotoxemia is likely to be associated with alterations of the gut microbiota, because antibiotic treatment reduced cecal and systemic LPS levels in parallel with reduced glucose intolerance and fat mass development (34).”
BackgroundRegulation of energy balance by a gut–brain axis and involvement of the gut microbiota
Bauer, P. V., Hamr, S. C., & Duca, F. A. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2083-z · Cited by 216
“For example, studies in mice demonstrate that antibiotic treatment can have beneficial effects on lowering body weight and food intake in high fat fed adult mice [220, 221].”
BackgroundGut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism
Soto, M., Herzog, C., Pacheco, J. A., Fujisaka, S., Bullock, K., Clish, C. B., & Kahn, C. R. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0086-5 · Cited by 216
“decreased after treatment with antibiotics [1, 8, 11].”
BackgroundInfluentialRole of Short Chain Fatty Acid Receptors in Intestinal Physiology and Pathophysiology
Priyadarshini, M., Kotlo, K. U., Dudeja, P. K., & Layden, B. T. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170050 · Cited by 212
“Though high-fat diet is associated with dysbiosis and mild inflammation (34), no inference was drawn regarding increase of intestinal inflammation promoting bacteria in the KO mice (120).”
Martínez, I., Perdicaro, D. J., Brown, A. W., Hammons, S., Carden, T. J., Carr, T. P., Eskridge, K. M., & Walter, J. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03046-12 · Cited by 215
Impact of Diet on Human Intestinal Microbiota and Health
Salonen, A., & de Vos, W. M. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182554 · Cited by 215
“Another reason that contributes to a more pronounced dietary impact on mice microbiota is the actual composition of diets used in interventions; Western-type, high-fat diets fed to mice can contain more than 70% of fat (Cani et al. 2008), whereas in humans, ethical and compliance issues limit the testing of extreme di…”
BackgroundBleau, C., Karelis, A. D., St‐Pierre, D. H., & Lamontagne, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2617 · Cited by 215
“Furthermore, growing rodent and human evidences suggest that subclinical endotoxemia may be involved in the pathogenesis of type 2 diabetes, obesity and other metabolic diseases [7, 70, 111, 112].”
BackgroundInfluentialLy, N. P., Litonjua, A., Gold, D. R., & Celedón, J. C. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.015 · Cited by 214
“Cani et al(104) demonstrated that mice fed a high-fat diet for 2 to 4 weeks exhibited a significant increase in circulating LPS levels (described as ‘‘metabolic endotoxemia’’) and that these mice became obese and had obesityassociated metabolic disorders.(104,105) Similarly, mice infused with LPS (to reach levels obse…”
BackgroundNaito, E., Yoshida, Y., Makino, K., Kounoshi, Y., Kunihiro, S., Takahashi, R., Matsuzaki, T., Miyazaki, K., & Ishikawa, F. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04922.x · Cited by 214
“An increase in intestinal permeability has been proposed as a mechanism for the development of metabolic endotoxaemia (Brun et al. 2007; Cani et al. 2007, 2008).”
BackgroundInfluentialSchéle, E., Grahnemo, L., Anesten, F., Hallén, A., Bäckhed, F., & Jansson, J.-O. (2013) · Endocrinology · doi:10.1210/en.2012-2151 · Cited by 209
“of obese mice with antibiotics similarly reduces body weight and improves glucose metabolism (6, 7).”
BackgroundIntegrative Personal Omics Profiles during Periods of Weight Gain and Loss
Piening, B. D., Zhou, W., Contrepois, K., Röst, H., Gu Urban, G. J., Mishra, T., Hanson, B. M., Bautista, E. J., Leopold, S., Yeh, C. Y., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.013 · Cited by 212
“, 2006, 2009), and in mice there is evidence that low-grade inflammation associated with weight gain is at least partially due to the microbiome (Cani et al., 2008).”
BackgroundImpact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD)
Battineni, G., Sagaro, G. G., Chintalapudi, N., Amenta, F., Tomassoni, D., & Tayebati, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094798 · Cited by 208
Dietary fat and gut microbiota interactions determine diet-induced obesity in mice
Kübeck, R., Bonet-Ripoll, C., Hoffmann, C., Walker, A., Müller, V. M., Schüppel, V. L., Lagkouvardos, I., Scholz, B., Engel, K.-H., Daniel, H., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.10.001 · Cited by 211
Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk
Neves, A. L., Coelho, J., Couto, L., Leite-Moreira, A., & Roncon-Albuquerque, R. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0079 · Cited by 211
“In physiological conditions, the intestinal epithelium acts as a continuous barrier to avoid LPS translocation; however, some endogenous or exogenous events may alter this protective function (Cani et al. 2008).”
BackgroundResultInfluentialDey, P. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104367 · Cited by 209
Kim, S.-W., Park, K.-Y., Kim, B., Kim, E., & Hyun, C.-K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.121 · Cited by 209
The intestinal microbiota and obesity
Kallus, S. J., & Brandt, L. J. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31823711fd · Cited by 210
Nesci, A., Carnuccio, C., Ruggieri, V., D’Alessandro, A., Di Giorgio, A., Santoro, L., Gasbarrini, A., Santoliquido, A., & Ponziani, F. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109087 · Cited by 208
“, plasminogen activator inhibitor-1, IL-1, and TNF-α mRNA) [127].”
Dehghan, P., Pourghassem Gargari, B., & Asghari Jafar-abadi, M. (2014) · Nutrition · doi:10.1016/j.nut.2013.09.005 · Cited by 207
Houlden, A., Hayes, K. S., Bancroft, A. J., Worthington, J. J., Wang, P., Grencis, R. K., & Roberts, I. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125945 · Cited by 209
Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children
Balamurugan, R., George, G., Kabeerdoss, J., Hepsiba, J., Chandragunasekaran, A. M. S., & Ramakrishna, B. S. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509992182 · Cited by 207
“Obesity has been shown to be associated with increases in intestinal permeability and in plasma LPS in mice fed a high-fat diet; similar increases in plasma LPS were noted in ob/ob mice ingesting normal chow((30)).”
BackgroundSuzuki, T., & Hara, H. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-19 · Cited by 209
“Recently, obesity and diabetes have been characterized by low-grade chronic systemic inflammation [2], and an innovative hypothesis was proposed: this systemic inflammation is closely linked to the plasma endotoxemia resulting from increased intestinal permeability in obese animals [3,4].”
BackgroundResultInfluentialImpact of Gut Microbiota on Host Glycemic Control
Gérard, C., & Vidal, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00029 · Cited by 209
“Conversely, in case of disturbances in the equilibrium of the gut microbiota, intestinal permeability, and translocation of LPS-related endotoxemia increase (114, 115).”
BackgroundThe gut microbiota metabolite indole alleviates liver inflammation in mice
Beaumont, M., Neyrinck, A. M., Olivares, M., Rodriguez, J., de Rocca Serra, A., Roumain, M., Bindels, L. B., Cani, P. D., Evenepoel, P., Muccioli, G. G., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800544 · Cited by 207
Self-citationSong, X., Zhong, L., Lyu, N., Liu, F., Li, B., Hao, Y., Xue, Y., Li, J., Feng, Y., Ma, Y., et al. (2019) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.03.001 · Cited by 208
Li, X., Watanabe, K., & Kimura, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01882 · Cited by 205
“This cross talk is mediated by gut microbiota as shown by the abrogation of these metabolic endotoxemia-induced phenotypes along with a decrease in inflammation markers and intestinal permeability after an antibiotic treatment (17).”
BackgroundLi, K., Zhang, L., Xue, J., Yang, X., Dong, X., Sha, L., Lei, H., Zhang, X., Zhu, L., Wang, Z., et al. (2019) · Food & Function · doi:10.1039/c8fo02265h · Cited by 206
Gut-associated IgA+ immune cells regulate obesity-related insulin resistance
Luck, H., Khan, S., Kim, J. H., Copeland, J. K., Revelo, X. S., Tsai, S., Chakraborty, M., Cheng, K., Tao Chan, Y., Nøhr, M. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11370-y · Cited by 205
Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1843396 · Cited by 207
Intestinal microbiota is a plastic factor responding to environmental changes
Candela, M., Biagi, E., Maccaferri, S., Turroni, S., & Brigidi, P. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.05.003 · Cited by 206
Hwang, I., Park, Y. J., Kim, Y., Kim, Y. N., Ka, S., Lee, H. Y., Seong, J. K., Seok, Y., & Kim, J. B. (2015) · The FASEB Journal · doi:10.1096/fj.14-265983 · Cited by 206
“This examination is based on the intestinal permeability to 4000Da fluorescent-dextran (46944; Sigma-Aldrich) as previously described (9).”
BackgroundMethodResultInfluentialDynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression
Peled, M., & Fisher, E. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00579 · Cited by 205
Gut Microbiome and Obesity: A Plausible Explanation for Obesity
Sanmiguel, C., Gupta, A., & Mayer, E. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0152-0 · Cited by 204
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Sookoian, S., Salatino, A., Castaño, G. O., Landa, M. S., Fijalkowky, C., Garaycoechea, M., & Pirola, C. J. (2020) · Gut · doi:10.1136/gutjnl-2019-318811 · Cited by 201
Role of DUOX in gut inflammation: lessons from Drosophila model of gut-microbiota interactions
Kim, S.-H., & Lee, W.-J. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00116 · Cited by 202
A. Parnell, J., & A. Reimer, R. (2012) · Gut Microbes · doi:10.4161/gmic.19246 · Cited by 203
“On the other hand, antibiotic induced changes in the gut microbiota reduced metabolic endotoxemia in genetically obese and diet-induced, obese mice.(20) Bacterial colonization begins at, or possibly before birth,(21) and can be influenced throughout the lifespan by a variety of factors, of which diet is a key contribu…”
BackgroundYan, H., Lu, J., Wang, Y., Gu, W., Yang, X., & Yu, J. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.01.007 · Cited by 203
Gut microbiota influences pathological angiogenesis in obesity‐driven choroidal neovascularization
Andriessen, E. M., Wilson, A. M., Mawambo, G., Dejda, A., Miloudi, K., Sennlaub, F., & Sapieha, P. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606531 · Cited by 201
Gut microbiota, diet, and obesity-related disorders: the good, the bad, and the future challenges
Portune, K. J., Benítez‐Páez, A., Del Pulgar, E. M. G., Cerrudo, V., & Sanz, Y. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600252 · Cited by 201
“In mice, reduced expression of several genes encoding tight junction proteins (zona occludens-1 and occludin) were reduced in groups undergoing HFD feeding [32].”
BackgroundHigh-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids
Stenman, L. K. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i9.923 · Cited by 201
Current understanding of metformin effect on the control of hyperglycemia in diabetes
An, H., & He, L. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0447 · Cited by 202
“An earlier study showed that high-fat-diet feeding increases the intestinal permeability of LPS (Cani et al. 2007, 2008, Creely et al. 2007, Oliveira et al. 2011), and AMPK plays a critical role in maintaining intestinal barrier integrity (Peng et al. 2009, Elamin et al. 2013).”
Ling, X., Linglong, P., Weixia, D., & Hong, W. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161635 · Cited by 200
Shen, H., Guan, Q., Zhang, X., Yuan, C., Tan, Z., Zhai, L., Hao, Y., Gu, Y., & Han, C. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109884 · Cited by 201
Mas-Capdevila, A., Teichenne, J., Domenech-Coca, C., Caimari, A., Del Bas, J. M., Escoté, X., & Crescenti, A. (2020) · Nutrients · doi:10.3390/nu12051488 · Cited by 201
Adipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2025) · Nature Reviews Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 192
“For example, obesity and type 2 diabetes are characterized by ‘metabolic endotoxaemia’ in which endotoxin (derived from commensal bacteria) contributes to systemic inflammation 271,272 .”
Teixeira, T. F. S., Souza, N. C. S., Chiarello, P. G., Franceschini, S. C. C., Bressan, J., Ferreira, C. L. L. F., & Peluzio, M. D. C. G. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.02.009 · Cited by 201
Interaction between gut microbiota and toll-like receptor: from immunity to metabolism
Yiu, J. H. C., Dorweiler, B., & Woo, C. W. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1474-4 · Cited by 200
“High-fat intake or obesity can weaken the gut integrity leading to penetration of gut microbes or their products into the circulation [45].”
BackgroundDiet-microbiota interactions and their implications for healthy living
Jeffery, I., & O'Toole, P. (2013) · Nutrients · doi:10.3390/nu5010234 · Cited by 199
“Cani et al. (2008) [105] showed that genetically obese ob/ob mice, which are characterised by obesity and insulin resistance, showed an improvement in insulin sensitivity and inflammatory parameters when treated with antibiotics.”
BackgroundInvolvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis
Schepper, J. D., Collins, F., Rios-Arce, N. D., Kang, H. J., Schaefer, L., Gardinier, J. D., Raghuvanshi, R., Quinn, R. A., Britton, R., Parameswaran, N., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3947 · Cited by 199
Metadata
- Authors
- Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R.
- Affiliations
- UCLouvain (BE)
- Nestlé (Switzerland) (CH)
- Rangueil Institute of Molecular Medicine, Toulouse, France
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1470-1481
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129917444
- Cited by
- 4,819
- References
- 47
- Citations by year
- 2026: 223 · 2025: 240 · 2024: 305 · 2023: 319 · 2022: 397 · 2021: 420 · 2020: 389 · 2019: 396 · 2018: 368 · 2017: 319 · 2016: 319 · 2015: 292 · 2014: 199 · 2013: 187 · 2012: 149
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Digital Access to Libraries (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-05-PNRA-004, ANR-05)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- gut microbiota, metabolic endotoxemia, lipopolysaccharide, high-fat diet, obesity, type 2 diabetes, low-grade inflammation, antibiotic therapy, intestinal permeability, tight junctions, CD14, visceral adipose tissue, oxidative stress, impaired glucose tolerance, ob/ob mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Bacteroides, Base Sequence, Bifidobacterium, Cecum, Crosses, Genetic, Diabetes Mellitus, Experimental, Feces, Female, Genotype, Inflammation, Lactobacillus, Male, Mice, Inbred C57BL, Mice, Obese, Obesity, RNA, Bacterial, Endotoxemia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.